Curanex Pharmaceuticals CURX
NASDAQ CURX
$4.92 -0.06 (-1.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

Curanex Pharmaceuticals (CURX) Cash & Equivalents (2024 - 2026)

Updated

Curanex Pharmaceuticals (CURX) recorded Cash & Equivalents of $2.94 million in Q2 2026, compared with $108,862 a year earlier.

Analysis

Curanex Pharmaceuticals (CURX) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, Curanex Pharmaceuticals reported Cash & Equivalents of $4.97 million.

  • Across earlier years, Cash & Equivalents came in at $148,891 in FY2024.
  • Quarterly Cash & Equivalents has ranged from $108,862 in Q2 2025 to $5.83 million in Q3 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Curanex Pharmaceuticals 6.98 Mn -6.87 Mn - 2.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.94 Mn
Dec 31, 2025 4.97 Mn
Sep 30, 2025 5.83 Mn
Jun 30, 2025 108,862.00
Dec 31, 2024 148,891.00
Sep 30, 2024 244,317.00
API Access

Curanex Pharmaceuticals Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CURX&period=max&api_key=YOUR_API_KEY